1
2
3
4
5
6
7
8
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
由 Hymowitz, Sarah G., Jin, Sha, Khaw, Seong Lin, Kovar, Peter J., Lam, Lloyd T., Lee, Jackie, Maecker, Heather L., Marsh, Kennan C., Mason, Kylie D., Mitten, Michael J., Sampath, Deepak, Nimmer, Paul M., Oleksijew, Anatol, Park, Chang H., Park, Cheol-Min, Phillips, Darren C., Roberts, Andrew W., Seymour, John F., Smith, Morey L., Sullivan, Gerard M., Tahir, Stephen K., Wendt, Michael D., Xiao, Yu, Xue, John C., Zhang, Haichao, Humerickhouse, Rod A., Rosenberg, Saul H., Elmore, Steven W., Tse, Chris, Souers, Andrew J., Leverson, Joel D., Boghaert, Erwin R., Ackler, Scott L., Catron, Nathaniel D., Chen, Jun, Dayton, Brian D., Ding, Hong, Enschede, Sari H., Fairbrother, Wayne J., Huang, David C. S.
出版 2013
獲取全文出版 2013
獲取全文
獲取全文
Article